KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Depreciation & Amortization - Total (2024 - 2025)

Globus Medical (GMED) has disclosed Depreciation & Amortization - Total for 2 consecutive years, with $30.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 7.1% year-over-year to $30.1 million, compared with a TTM value of $88.7 million through Dec 2025, down 12.1%, and an annual FY2024 reading of $100.9 million, up 40.66% over the prior year.
  • Depreciation & Amortization - Total was $30.1 million for Q3 2025 at Globus Medical, up from $29.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $30.1 million in Q3 2025 and bottomed at $17.3 million in Q1 2024.